Novartis CEO Predicts Drug Policy Shift

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Novartis leadership warned that the reality of new US drug pricing policies will significantly impact pharmaceutical margins and R&D over the next 18 months.

Actual Topics